Recent Publications by CTL

CTL prides itself of an active, in-house ELISPOT/FluoroSpot-oriented research effort that aims to further this technology’s readiness for the immune monitoring community. Meet our 22 MD/PhD level scientists and learn what motivates them. Here are their latest contributions: